<Record>
<Term>Antiparkinson Agents</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Chemical Viewed Functionally</SemanticType>
<ParentTerm>Adjuvant</ParentTerm>
<ParentTerm>Anti-Dyskinesia Agents</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Antiparkinsonian Agent</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Central Nervous System Agents/Anti-Dyskinesia Agents/Antiparkinson Agents</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antiparkinson Agents</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Anti-Dyskinesia Agents</BroaderTerm>
<BroaderTerm>Antiparkinsonian Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Central Nervous System Agents</BroaderTerm>
<ChildTerm>Ethopropazine</ChildTerm>
<ChildTerm>Biperiden</ChildTerm>
<ChildTerm>Biperiden Hydrochloride</ChildTerm>
<ChildTerm>Procyclidine Hydrochloride</ChildTerm>
<ChildTerm>Cabergoline</ChildTerm>
<ChildTerm>Trihexyphenidyl</ChildTerm>
<ChildTerm>Cycrimine</ChildTerm>
<ChildTerm>Apomorphine Hydrochloride</ChildTerm>
<ChildTerm>Cycrimine Hydrochloride</ChildTerm>
<ChildTerm>Flunamine</ChildTerm>
<ChildTerm>Carbidopa</ChildTerm>
<ChildTerm>Methixene</ChildTerm>
<ChildTerm>Trihexyphenidyl Hydrochloride</ChildTerm>
<ChildTerm>Pergolide Mesylate</ChildTerm>
<ChildTerm>Apomorphine</ChildTerm>
<ChildTerm>Oxiperomide</ChildTerm>
<ChildTerm>Rasagiline Mesylate</ChildTerm>
<ChildTerm>Ropinirole Hydrochloride</ChildTerm>
<ChildTerm>Botiacrine</ChildTerm>
<ChildTerm>Pergolide</ChildTerm>
<ChildTerm>Biperiden Lactate</ChildTerm>
<ChildTerm>Entacapone</ChildTerm>
<ChildTerm>Rasagiline</ChildTerm>
<ChildTerm>L-Carbidopa Anhydrous</ChildTerm>
<ChildTerm>Piroheptine</ChildTerm>
<ChildTerm>Pareptide</ChildTerm>
<ChildTerm>Pramipexole Dihydrochloride</ChildTerm>
<ChildTerm>Istradefylline</ChildTerm>
<ChildTerm>Memantine Hydrochloride</ChildTerm>
<ChildTerm>Tolcapone</ChildTerm>
<ChildTerm>Budipine</ChildTerm>
<ChildTerm>Diprobutine</ChildTerm>
<ChildTerm>Ropinirole</ChildTerm>
<ChildTerm>Droxidopa</ChildTerm>
<ChildTerm>Memantine</ChildTerm>
<Synonym>Antiparkinson Agents</Synonym>
<Synonym>Antiparkinsonian Agent</Synonym>
<Synonym>Antiparkinson Drugs</Synonym>
<Synonym>Antiparkinsonians</Synonym>
<Synonym>Antiparkinsonian Agents</Synonym>
<Description>Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.</Description>
<Source>NCI Thesaurus</Source>
<Source>MeSH</Source>
</Record>
